@cancers-mdpi.bsky.social📖The Relationship Between #Response Rate and #Survival Benefits in Randomized #Immunotherapy Studies
📝by Aditi Jain and Justin Stebbing
🏫 @edinburgh-uni.bsky.social , @angliaruskin.bsky.social
📈12 citations
Find out more👉 www.mdpi.com/2072-6694/17...
@sigtrans-sttt.bsky.socialWho benefits most from consolidation #Immunotherapy in limited-stage #SCLC?
Integrating #ctDNA status with tumor shrinkage identifies high-risk patients deriving survival benefit, while sustained ctDNA negativity predicts favorable outcomes.
@gmj-georgia.bsky.socialResearchers have developed COMPASS, a breakthrough AI model that predicts immunotherapy response across multiple cancer types using tumor gene expre… #Artificialintelligence #Cancertreatment #Immunotherapy #Oncology #Precisionmedicine #Artificialintelligence #Cancertreatment #Immunotherapy #Onc…
@carlus-2024.bsky.socialSeptember 5, 2026
👉 What if we could make cancer cells vulnerable to immunotherapy again?
🙂 Another encouraging news from Groupe UIG.
Read: lnkd.in/gwMarPZs
#CancerResearch #Immunotherapy #ImmunoOncology #PrecisionMedicine #Oncology #Biotech
@jem.orgAre you headed to @cshasia.bsky.social meeting on #cancer #immunotherapy in Suzhou? Meet our Deputy Editor, Gaia Trincucci (@gaiajexpmed.bsky.social), to discuss your research in person!
👉 Email Gaia: rupress.org/jem/pages/ed...
Read our new collection on the topic:
👉 rupress.org/jem/collecti...
@rupress.orgExplore @jem.org's new collection highlighting the latest discoveries in #cancer #immunology and #immunotherapy, timed to coincide with the @cshasia.bsky.social meeting on the topic in Suzhou, China.
👉 rupress.org/jem/collecti...
@jem.orgExplore JEM's new collection highlighting the latest discoveries in #cancer #immunology and #immunotherapy, timed to coincide with the @cshasia.bsky.social meeting on the topic in Suzhou, China.
👉 rupress.org/jem/collecti...
@tumorijournal.bsky.social🆕This study provides an innovative technological framework and preclinical evidence supporting localized mRNA-based #immunotherapy for #bladdercancer.
🔗https://journals.sagepub.com/share/5YFXQYE3FJZFSKNMTDFT?target=10.1177/03008916261463130
@drtimos.bsky.social🚀 Get the #Oncology buzz from #ASCOGI25!
Top themes: #Efficacy 16.2%, #ClinicalTrials 16.1%, #Data 15.9%. #CRCsm & #GIOnc dominate, with #ctDNA & #Immunotherapy hot topics. 📊🩺
Download our full report! http://dlvr.it/TVJN5b
@ASCO
#SocialListening #LucidQuest
@sigtrans-sttt.bsky.socialCould #GutMicrobiota boost #Cancer #Immunotherapy?
Single-cell analysis shows microbiota–ICI synergy restores exhausted CD8+ T-cells, shifts macrophage reprogramming, and activates γδ T cell–APC–CD8+ T cell axis.
@cancers-mdpi.bsky.social📌Editor's Choice Paper
Current Treatment Standards for Metastatic #UvealMelanoma
🧑⚕️Paweł Rogala, Anna M. Czarnecka et al.
🗝️Keywords: uveal melanoma; #metastases; liver-directed therapy; #immunotherapy; tebentafusp; anti-PD1
Read here🔎 www.mdpi.com/2072-6694/18...
@gmj-georgia.bsky.socialBreakthrough: Engineered T-cell therapy targeting three tumor proteins shows early survival gains in children with diffuse intrinsic pontine glioma (DIPG) and rel… #Braincancer #Celltherapy #Clinicaltrial #DIPG #Immunotherapy #Braincancer #Celltherapy #Clinicaltrial #DIPG #Immunotherapy https:…